Patent №
US 5,910,109
Granted
1999-06-08
Filed 1997
Owner
EMERGING TECHNOLOGY SYSTEMS, LLC
+3 more
Lab
—
AI components
1
ml
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
08803066
A glucose measuring device for determining the concentration of glucose in intravascular blood within a body part of a subject. The device includes light sources having a wavelength of 650, 880, 940 or 1300 nm to illuminate the fluid. Receptors associated with the light sources for receiving light and generating a transmission signal representing the light transmitted are also provided. A support piece is including for supporting the light sources associated with their respective light sources. The support piece is adapted to engage a body part of a subject. Finally, a signal analyzer, which includes a trained neural network, determines the glucose concentration in the blood of the subject. A method for determining the glucose concentration is also provided which calibrates a measuring device and sets the operating current for illuminating the light sources during operation of the device. Once a transmission signal is generated by receptors receiving light via the light sources and illuminated blood, and the high and low values from each of the signals are stored in the device, and averaged to obtain a single transmission value for each of the light sources. The averaged values are then analyzed to determine the glucose concentration, which value is displayed on the device.
AI classification
Ownership
EMERGING TECHNOLOGY SYSTEMS, LLC
assignment · 85850794
LIFETRAC SYSTEMS INCORPORATED
assignment · 166410903
T.G.D. CORP., INC.
assignment · 175860107
INNOVATIVE MEDICAL TECHNOLOGIES SYSTEMS, INC.
assignment · 175860135
Assignors
PETERS, RICHARD K., ELMERICK, DONALD
On an employer assignment, the assignors are typically the inventors.